STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products. In addition, this segment offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The company's Healthcare Specialty Services segment provides solutions, and outsourced and managed services for acute care hospitals and other healthcare settings, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting services. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The company's Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 50 facilities. The company was founded in 1985 and is headquartered in Leicester, the United Kingdom.
Industry, Sector and Symbol
Industry Surgical appliances & supplies
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNYSE:STE
CUSIP85915210
Phone44-13-3238-7100
Debt
Debt-to-Equity Ratio0.41
Current Ratio2.48
Quick Ratio1.97
Price-To-Earnings
Trailing P/E Ratio25.78
Forward P/E Ratio22.70
P/E GrowthN/A
Sales & Book Value
Annual Sales$2.62 billion
Price / Sales3.45
Cash Flow$6.3054 per share
Price / Cash16.96
Book Value$37.92 per share
Price / Book2.82
Profitability
EPS (Most Recent Fiscal Year)$4.15
Net Income$290.91 million
Net Margins11.10%
Return on Equity11.55%
Return on Assets6.93%
Miscellaneous
Employees12,000
Outstanding Shares84,620,000
Steris (NYSE:STE) Frequently Asked Questions
What is Steris' stock symbol?
Steris trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."
How often does Steris pay dividends? What is the dividend yield for Steris?
Steris declared a quarterly dividend on Friday, May 11th. Investors of record on Friday, June 8th will be given a dividend of $0.31 per share on Thursday, June 28th. This represents a $1.24 annualized dividend and a yield of 1.16%. The ex-dividend date of this dividend is Thursday, June 7th. View Steris' Dividend History.
How were Steris' earnings last quarter?
Steris PLC (NYSE:STE) announced its quarterly earnings results on Wednesday, May, 9th. The medical equipment provider reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.02. The medical equipment provider earned $716 million during the quarter, compared to analysts' expectations of $703.37 million. Steris had a net margin of 11.10% and a return on equity of 11.55%. Steris's revenue for the quarter was up 5.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.11 EPS. View Steris' Earnings History.
When is Steris' next earnings date?
What guidance has Steris issued on next quarter's earnings?
Steris updated its FY19 earnings guidance on Wednesday, May, 9th. The company provided earnings per share (EPS) guidance of $4.63-$4.75 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.69.
What price target have analysts set for STE?
4 Wall Street analysts have issued 12-month price objectives for Steris' shares. Their forecasts range from $16.00 to $103.00. On average, they anticipate Steris' stock price to reach $80.25 in the next year. View Analyst Ratings for Steris.
Who are some of Steris' key competitors?
Some companies that are related to Steris include Edwards Lifesciences (EW), Align Technology (ALGN), Zimmer Biomet (ZBH), COLOPLAST A/S/ADR (CLPBY), Smith & Nephew (SNN), WILLIAM DEMANT/ADR (WILYY), Inogen (INGN), MSA Safety (MSA), Halyard Health (HYH), Wright Medical Group (WMGI), Invacare (IVC), Consort Medical (CSRMY), Sientra (SIEN), RTI Surgical (RTIX) and Lakeland Industries (LAKE).
Who are Steris' key executives?
Steris' management team includes the folowing people:
- Mr. Walter M. Rosebrough Jr., Pres, CEO & Director (Age 64)
- Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
- Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
- Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies and Life Sciences (Age 45)
- Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)
Has Steris been receiving favorable news coverage?
News articles about STE stock have trended somewhat positive on Thursday, according to Accern. The research firm identifies positive and negative news coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Steris earned a media sentiment score of 0.15 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 44.68 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the near future.
Who are Steris' major shareholders?
Steris' stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (8.81%), Massachusetts Financial Services Co. MA (2.55%), Westfield Capital Management Co. LP (1.95%), Principal Financial Group Inc. (1.93%), Principal Financial Group Inc. (1.93%) and Fisher Asset Management LLC (1.71%). Company insiders that own Steris stock include Adrian Vincent Coward, Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Kathleen Bardwell, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa, Walter M Rosebrough Jr and Walter M Rosebrough, Jr. View Institutional Ownership Trends for Steris.
Which major investors are selling Steris stock?
STE stock was sold by a variety of institutional investors in the last quarter, including Principal Financial Group Inc., Principal Financial Group Inc., Champlain Investment Partners LLC, Envestnet Asset Management Inc., Fisher Asset Management LLC, Westfield Capital Management Co. LP, Daiwa Securities Group Inc. and Public Employees Retirement Association of Colorado. Company insiders that have sold Steris company stock in the last year include Cynthia L Feldmann, Daniel A Carestio, Jacqueline B Kosecoff, John Adam Zangerle, Karen L Burton, Loyal W Wilson, Michael B Wood, Michael J Tokich, Mohsen Sohi, Richard Martin Steeves, Sudhir K Pahwa and Walter M Rosebrough Jr. View Insider Buying and Selling for Steris.
Which major investors are buying Steris stock?
STE stock was bought by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., Robeco Institutional Asset Management B.V., BlackRock Inc., Massachusetts Financial Services Co. MA, Prudential Financial Inc., American Century Companies Inc., Wells Fargo & Company MN and Chicago Equity Partners LLC. View Insider Buying and Selling for Steris.
How do I buy shares of Steris?
Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Steris' stock price today?
One share of STE stock can currently be purchased for approximately $106.93.
How big of a company is Steris?
Steris has a market capitalization of $9.03 billion and generates $2.62 billion in revenue each year. The medical equipment provider earns $290.91 million in net income (profit) each year or $4.15 on an earnings per share basis. Steris employs 12,000 workers across the globe.
How can I contact Steris?
Steris' mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]
MarketBeat Community Rating for Steris (STE)
MarketBeat's community ratings are surveys of what our community members think about Steris and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.
